← Open Payments lookup

DEBORAH WHATLEY: Open Payments

NPI 1184110900 · LEXINGTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,087 in 219 payments from 14 companies in 2025. Trend: 2023 $2,697 · 2024 $2,833 · 2025 $3,087

Food & beverage: $3,087
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.47$444
Neurocrine BioSciences, Inc.36$420
ABBVIE INC.40$385
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)20$379
E.R. Squibb & Sons, L.L.C.17$306
Alkermes, Inc.14$266
Otsuka America Pharmaceutical, Inc.17$260
Janssen Pharmaceuticals, Inc6$234
Vanda Pharmaceuticals Inc.11$168
Supernus Pharmaceuticals, Inc.4$86

Products named: INGREZZA, CAPLYTA, VRAYLAR, COBENFY, AUSTEDO XR, ARISTADA, INVEGA SUSTENNA, UZEDY.

Industry payments across SC — which companies pay providers there.